miR-146a, an IL-1β responsive miRNA, induces vascular endothelial growth factor and chondrocyte apoptosis by targeting Smad4

IntroductionmiR-146a is one of the first identified miRNAs expressed differentially in osteoarthritis (OA) cartilage. However, the role it plays in OA pathogenesis is not clear. The aim of this study is to identify a molecular target of miR-146a, thereby elucidating its function in chondrocytes during OA pathogenesis.MethodsPrimary chondrocytes from Sprague-Dawley rats were treated with IL-1β before the expression levels of miR-146a, Smad4 and vascular endothelial growth factor (VEGF) were quantified by real-time PCR and/or western blotting. The effect of miR-146a on cellular response to transforming growth factor (TGF)-β1 was quantified by a luciferase reporter harboring TGF-β1 responsive elements and by extracellular signal-regulated kinase assay. The effect of miR-146a on apoptosis was quantified by the TUNEL assay. OA pathogenesis was surgically induced with joint instability in rats, evaluated by histopathological analysis with safranin O staining, and the expression levels of miR-146a, Smad4, and VEGF were quantified using real-time PCR and/or immunohistochemistry.ResultsIL-1β treatment of chondrocytes increased the expression levels of miR-146a and VEGF and decreased the levels of Smad4 in a time-dependent manner. miR-146a upregulated VEGF expression and downregulated Smad4 expression in chondrocytes, while a miR-146a inhibitor acted in a converse manner. Smad4, a common mediator of the TGF-β pathway, is identified as a direct target of miR-146a by harboring a miR-146a binding sequence in the 3'-UTR region of its mRNA. Mutation of the binding sequence significantly relieved the inhibition of the Smad4 reporter activity by miR-146a. Furthermore, miR-146a upregulation of VEGF is mediated by Smad4. Expression of miR-146a led to a reduction of cellular responsiveness to TGF-β and an increase of apoptosis rate in chondrocytes. In vivo, cartilage from surgically induced OA rats displayed higher levels of miR-146a and VEGF compared with the sham group. In contrast, Smad4 expression level was lower in the OA group than the sham group.ConclusionIL-1β responsive miR-146a is overexpressed in an experimentally induced OA model, accompanied by upregulation of VEGF and downregulation of Smad4 in vivo. miR-146a may contribute to OA pathogenesis by increasing VEGF levels and by impairing the TGF-β signaling pathway through targeted inhibition of Smad4 in cartilage.

[1]  S. Krane,et al.  Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes. , 1988, The Journal of clinical investigation.

[2]  A. Mauviel,et al.  Transforming growth factor beta exerts opposite effects from interleukin-1 beta on cultured rabbit articular chondrocytes through reduction of interleukin-1 receptor expression. , 1993, Arthritis and rheumatism.

[3]  Q. Chen,et al.  Progression and recapitulation of the chondrocyte differentiation program: cartilage matrix protein is a marker for cartilage maturation. , 1995, Developmental biology.

[4]  Mahlon D. Johnson,et al.  Expression of a Truncated, Kinase-Defective TGF-β Type II Receptor in Mouse Skeletal Tissue Promotes Terminal Chondrocyte Differentiation and Osteoarthritis , 1997, The Journal of cell biology.

[5]  M. Lotz,et al.  Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis. , 1998, Arthritis and rheumatism.

[6]  F. Blanco,et al.  Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology. , 1998, Arthritis and rheumatism.

[7]  Napoleone Ferrara,et al.  VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation , 1999, Nature Medicine.

[8]  O. Volpert,et al.  Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[9]  R. Cancedda,et al.  Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. J Cell Sci 113(Pt 1):59-69 , 2000 .

[10]  R. Cancedda,et al.  Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. , 2000, Journal of cell science.

[11]  B. Nicke,et al.  Smad4 mediates activation of mitogen-activated protein kinases by TGF-beta in pancreatic acinar cells. , 2001, American journal of physiology. Cell physiology.

[12]  C. Deng,et al.  TGF-β/Smad3 Signals Repress Chondrocyte Hypertrophic Differentiation and Are Required for Maintaining Articular Cartilage , 2001, The Journal of cell biology.

[13]  C. Brinckerhoff,et al.  Early response genes induced in chondrocytes stimulated with the inflammatory cytokine interleukin-1beta , 2001, Arthritis research.

[14]  S. Abramson,et al.  Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. , 2001, Arthritis and rheumatism.

[15]  M. D. de Caestecker,et al.  Transcriptional Cross-talk between Smad, ERK1/2, and p38 Mitogen-activated Protein Kinase Pathways Regulates Transforming Growth Factor-β-induced Aggrecan Gene Expression in Chondrogenic ATDC5 Cells* , 2001, The Journal of Biological Chemistry.

[16]  G. Verbruggen,et al.  Control of extracellular matrix homeostasis of normal cartilage by a TGFbeta autocrine pathway. Validation of flow cytometry as a tool to study chondrocyte metabolism in vitro. , 2002, Osteoarthritis and cartilage.

[17]  D. Heymann,et al.  Recent advances in TGF-beta effects on chondrocyte metabolism. Potential therapeutic roles of TGF-beta in cartilage disorders. , 2002, Cytokine & growth factor reviews.

[18]  D. Heymann,et al.  Recent advances in TGF-β effects on chondrocyte metabolism , 2002 .

[19]  H. Schnaper,et al.  Cross‐talk between ERK MAP kinase and Smad‐signaling pathways enhances TGF‐β dependent responses in human mesangial cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  J. Massagué,et al.  Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.

[21]  J. Massagué,et al.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus. , 2003, Cell.

[22]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[23]  M. Lotz,et al.  Accelerated, aging-dependent development of osteoarthritis in alpha1 integrin-deficient mice. , 2003, Arthritis and rheumatism.

[24]  D. Walsh,et al.  Inflammation and angiogenesis in osteoarthritis. , 2003, Arthritis and rheumatism.

[25]  P. Scherle,et al.  Induction of aggrecanase 1 (ADAM-TS4) by interleukin-1 occurs through activation of constitutively produced protein. , 2003, Arthritis and rheumatism.

[26]  Yoshiaki Toyama,et al.  Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. , 2003, The American journal of pathology.

[27]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[28]  E. Miska,et al.  MicroRNA functions in animal development and human disease , 2005, Development.

[29]  D. Thompson,et al.  Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis. , 2005, Osteoarthritis and cartilage.

[30]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[31]  Ji-shuai Zhang,et al.  Smad4 is required for the normal organization of the cartilage growth plate. , 2005, Developmental biology.

[32]  D. Walsh,et al.  Osteoarthritis, angiogenesis and inflammation. , 2005, Rheumatology.

[33]  D. D’Lima,et al.  Caspase inhibitors reduce severity of cartilage lesions in experimental osteoarthritis. , 2006, Arthritis and rheumatism.

[34]  B. Cillero-Pastor,et al.  Cytokines, tumor necrosis factor-alpha and interleukin-1beta, differentially regulate apoptosis in osteoarthritis cultured human chondrocytes. , 2006, Osteoarthritis and cartilage.

[35]  B. Cillero-Pastor,et al.  Cytokines, tumor necrosis factor-α and interleukin-1β, differentially regulate apoptosis in osteoarthritis cultured human chondrocytes , 2006 .

[36]  T. Dalmay,et al.  The cartilage specific microRNA‐140 targets histone deacetylase 4 in mouse cells , 2006, FEBS letters.

[37]  D. Baltimore,et al.  NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.

[38]  Michael Detmar,et al.  Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. , 2008, Arthritis and rheumatism.

[39]  Keiichiro Nishida,et al.  Expression of microRNA-146 in rheumatoid arthritis synovial tissue. , 2008, Arthritis and rheumatism.

[40]  Stijn van Dongen,et al.  miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..

[41]  Konstantinos N. Malizos,et al.  Integrative MicroRNA and Proteomic Approaches Identify Novel Osteoarthritis Genes and Their Collaborative Metabolic and Inflammatory Networks , 2008, PloS one.

[42]  Francis Berenbaum,et al.  Primary culture and phenotyping of murine chondrocytes , 2008, Nature Protocols.

[43]  C. Croce,et al.  MicroRNAs, the immune system and rheumatic disease , 2008, Nature Clinical Practice Rheumatology.

[44]  C. Croce.  Causes and consequences of microRNA dysregulation in cancer , 2009, Nature Reviews Genetics.

[45]  Xiao-Fan Wang,et al.  Signaling cross-talk between TGF-β/BMP and other pathways , 2009, Cell Research.

[46]  Yoshio Kato,et al.  MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. , 2009, Arthritis and rheumatism.

[47]  P. Tak,et al.  MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. , 2009, Arthritis and rheumatism.

[48]  J. Pelletier,et al.  Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes , 2009, BMC musculoskeletal disorders.

[49]  A. Reddi,et al.  Profiling microRNA expression in bovine articular cartilage and implications for mechanotransduction. , 2009, Arthritis and rheumatism.

[50]  Yi Luan,et al.  miR-199a*, a Bone Morphogenic Protein 2-responsive MicroRNA, Regulates Chondrogenesis via Direct Targeting to Smad1* , 2009, Journal of Biological Chemistry.

[51]  Efficient non-viral transfection of primary human adult chondrocytes in a high-throughput format. , 2009, Osteoarthritis and cartilage.

[52]  S. Miyaki,et al.  Expression of MicroRNA-146a in osteoarthritis cartilage. , 2009, Arthritis and rheumatism.

[53]  F. Voss,et al.  MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. , 2010, Arthritis and rheumatism.

[54]  S. Takada,et al.  MicroRNA-140 plays dual roles in both cartilage development and homeostasis. , 2010, Genes & development.

[55]  D. Walsh,et al.  Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis , 2010, Rheumatology.

[56]  Johanne Martel-Pelletier,et al.  Role of proinflammatory cytokines in the pathophysiology of osteoarthritis , 2011, Nature Reviews Rheumatology.

[57]  J. Kroin,et al.  MicroRNA-146a is linked to pain-related pathophysiology of osteoarthritis. , 2011, Gene.

[58]  Qian Chen,et al.  MiR‐365: a mechanosensitive microRNA stimulates chondrocyte differentiation through targeting histone deacetylase 4 , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.